Metyrapone (Synonyms: NSC 25265, SU 4885) |
Catalog No.GC17411 |
La métyrapone (Su-4885) est un inhibiteur de la 11β-hydroxylase puissant et actif par voie orale et un activateur de l'autophagie, inhibe également la production d'aldostérone.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 54-36-4
Sample solution is provided at 25 µL, 10mM.
Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.Target: CYP11B1Metyrapone is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Metyrapone blocks cortisol synthesis by reversibly inhibiting steroid 11β-hydroxylase. This stimulates ACTH secretion, which in turn increases plasma 11-Deoxycortisol levels.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *